OC
LH icon

Oppenheimer & Co’s Labcorp LH Stock Holding History

Oppenheimer & Co’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Hold
1,027
– – ﹤0.01% 1437
2025
Q4 		$258K Sell
1,027
-329
-24% -$87.4K ﹤0.01% 1331
2025
Q3 		$389K Sell
1,356
-9
-0.7% -$2.41K ﹤0.01% 1275
2025
Q2 		$358K Sell
1,365
-467
-25% -$114K ﹤0.01% 1270
2025
Q1 		$426K Sell
1,832
-275
-13% -$66.7K 0.01% 1127
2024
Q4 		$483K Sell
2,107
-450
-18% -$103K 0.01% 1072
2024
Q3 		$571K Sell
2,557
-285
-10% -$62.6K 0.01% 990
2024
Q2 		$578K Buy
2,842
+71
+3% +$14.4K 0.01% 962
2024
Q1 		$605K Buy
2,771
+59
+2% +$13K 0.01% 929
2023
Q4 		$616K Sell
2,712
-42
-2% -$8.82K 0.01% 903
2023
Q3 		$554K Sell
2,754
-230
-8% -$48.5K 0.01% 902
2023
Q2 		$619K Sell
2,984
-1,128
-27% -$219K 0.01% 898
2023
Q1 		$811K Sell
4,112
-1,566
-28% -$322K 0.02% 766
2022
Q4 		$1.15M Sell
5,678
-2,430
-30% -$475K 0.03% 621
2022
Q3 		$1.43M Buy
8,108
+109
+1% +$22.3K 0.03% 534
2022
Q2 		$1.61M Buy
7,999
+1,096
+16% +$234K 0.03% 524
2022
Q1 		$1.56M Buy
6,903
+1,951
+39% +$459K 0.03% 577
2021
Q4 		$1.34M Buy
4,952
+133
+3% +$32.9K 0.02% 663
2021
Q3 		$1.17M Buy
4,819
+297
+7% +$74.8K 0.02% 692
2021
Q2 		$1.07M Buy
4,522
+103
+2% +$23.5K 0.02% 722
2021
Q1 		$968K Buy
4,419
+20
+0.5% +$4.01K 0.02% 717
2020
Q4 		$769K Sell
4,399
-1,996
-31% -$345K 0.02% 738
2020
Q3 		$1.03M Buy
6,395
+112
+2% +$17.8K 0.03% 571
2020
Q2 		$896K Buy
6,283
+2,530
+67% +$350K 0.02% 608
2020
Q1 		$408K Buy
3,753
+796
+27% +$115K 0.01% 803
2019
Q4 		$430K Buy
2,957
+839
+40% +$121K 0.01% 893
2019
Q3 		$306K Buy
2,118
+9
+0.4% +$1.31K 0.01% 977
2019
Q2 		$314K Hold
2,109
– – 0.01% 987
2019
Q1 		$277K Sell
2,109
-151
-7% -$18.6K 0.01% 1070
2018
Q4 		$245K Sell
2,260
-936
-29% -$125K 0.01% 1025
2018
Q3 		$477K Sell
3,196
-199
-6% -$30.3K 0.01% 885
2018
Q2 		$524K Buy
3,395
+558
+20% +$84.2K 0.01% 844
2018
Q1 		$394K Buy
2,837
+31
+1% +$4.55K 0.01% 943
2017
Q4 		$385K Buy
2,806
+93
+3% +$12.3K 0.01% 962
2017
Q3 		$352K Sell
2,713
-349
-11% -$46.6K 0.01% 973
2017
Q2 		$405K Buy
3,062
+256
+9% +$31.3K 0.01% 907
2017
Q1 		$346K Buy
2,806
+17
+0.6% +$2.01K 0.01% 946
2016
Q4 		$309K Hold
2,789
– – 0.01% 981
2016
Q3 		$329K Hold
2,789
– – 0.01% 953
2016
Q2 		$312K Buy
2,789
+11
+0.4% +$1.18K 0.01% 956
2016
Q1 		$280K Sell
2,778
-971
-26% -$93.1K 0.01% 966
2015
Q4 		$398K Buy
3,749
+194
+5% +$20K 0.01% 852
2015
Q3 		$331K Buy
+3,555
New +$368K 0.01% 960
2015
Q1 		– Sell
-6,161
Closed -$571K – 1518
2014
Q4 		$571K Buy
+6,161
New +$544K 0.02% 773
2013
Q4 		– Sell
-2,407
Closed -$205K – 1428
2013
Q3 		$205K Sell
2,407
-232
-9% -$19.5K 0.01% 1151
2013
Q2 		$227K Buy
+2,639
New +$219K 0.01% 1046

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oppenheimer & Co's LH Position: Q1 2026 in Review

Oppenheimer & Co held its Labcorp (LH) position steady in Q1 2026 at 1,027 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Oppenheimer & Co first reported a position in LH in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.61M in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Oppenheimer & Co held 1,027 shares of Labcorp worth $274K as of Q1 2026.
  • Oppenheimer & Co left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1437 holding.
  • Oppenheimer & Co first reported a position in Labcorp in Q2 2013 and has held it in 46 quarters since.
  • Oppenheimer & Co's Labcorp position peaked at $1.61M in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.